INVO Fertility Stock (NASDAQ:IVF)

Revenue Ownership Financials Chart

Previous Close

$1.13

52W Range

$1.10 - $169.60

50D Avg

$1.54

200D Avg

$8.05

Market Cap

$1.57M

Avg Vol (3M)

$2.40M

Beta

2.29

Div Yield

-

IVF Company Profile

INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

42

IPO Date

Nov 02, 2020

Website

IVF Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/Service	Dec 25
Clinic Revenue	$6.72M
Product	$120.19K

Fiscal year ends in Dec 24 | Currency in USD

IVF Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	$6.53M	$3.02M	$822.20K
Operating Income	$-8.13M	$-6.77M	$-10.63M
Net Income	$-9.10M	$-8.03M	$-10.89M
EBITDA	$-7.14M	$-6.88M	$-10.75M
Basic EPS	$-30.19	$-5.13	$-8.99
Diluted EPS	$-30.19	$-5.13	$-8.99

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts

Q2 23Aug 14, 23 | 4:30 PM

Q1 23May 15, 23 | 4:30 PM

Q4 22Apr 17, 23 | 4:30 PM

Peer Comparison

Ticker	Company
CUTR	Cutera, Inc.
AXDX	Accelerate Diagnostics, Inc.